MILWAUKEE, Sept. 14, 2022 /PRNewswire/ -- Ademi LLP is investigating Ra Medical (NYSE American: RMED) for possible breaches of fiduciary duty and other violations of law in its transaction with Catheter Precision.
Click here to learn how to join the action: https://www.ademilaw.com/case/ra-medical-systems-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges Ra Medical transaction with Catheter Precision may not be fair to Ra Medical's shareholders.
We are investigating the conduct of Ra Medical's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
If you own Ra Medical common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/ra-medical-systems-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-ra-medical-systems-incs-transaction-with-catheter-precision-is-fair-to-shareholders-301624488.html
SOURCE Ademi LLP
